VCEL — Vericel Corporation stock price and chart

Share this page

VCEL

$40.13-2.17%

as of close, Oct 16, 2026

☾ AH $40.13 -2.17%

Vericel CorporationStock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.006%Russell 3000 0.003%US Stock Market 0.003%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

10.020.030.040.050.060.0020.0M40.0M$40.13

2026-10-16

Price$40.13

MA20$40.80

MA50$37.57

Vol3.2M

What would $1,000 invested in VCEL be worth today? →

VCEL returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $40.13
YTD price return: +11.44%
YTD total return: +11.44%
Next earnings: Nov 5, 2026
Market cap: 2.1B2016-12 72.3M2026-10 2.1B+2742.8% over the window
Enterprise value: 2B
Shares outstanding: 51.2M2016-06 24M2026-06 51.2M+113.4% over the window
52W low: $28.95
52W high: $49.32
From 52W high: -18.63%
From 52W low: +38.62%
52W range: 55%

Volume

Rel volume: 1.37×
30D volume: 536.2K
30D $ vol: 21.4M

Fundamentals

Sales (ttm): 306.3M2016-06 53.7M2026-06 306.3M+470.8% over the window
Sales/share: $5.982016-06 $2.242026-06 $5.98+167.5% over the window
EPS (ttm): $0.462018-09 -$0.302026-06 $0.46-249.3% over the window
FCF (ttm): 61.7M2016-12 -21.3M2026-06 61.7M-389.4% over the window
FCF/share: $1.202016-12 -$0.652026-06 $1.20-284.9% over the window
Book value/share: $7.232016-06 $0.712026-06 $7.23+913.6% over the window
Net margin: 7.91%2016-06 -29.9%2026-06 7.9%-126.5% over the window
ROE: 6.55%2016-06 -93.6%2026-06 6.5%-107.0% over the window
ROA: 4.82%2016-06 -54.4%2026-06 4.8%-108.8% over the window
Current ratio: 5.042016-06 1.952026-06 5.04+158.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +22.97%2025-06-30 → 2026-06-30249.1M → 306.3M (+23.0% total)+19.84%2023-06-30 → 2026-06-30178M → 306.3M (+72.1% total)+18.24%2020-12-31 → 2026-06-30122M → 306.3M (+151.1% total)+19.03%2016-06-30 → 2026-06-3053.7M → 306.3M (+470.8% total)
Net income: +241.09%2025-06-30 → 2026-06-307.1M → 24.2M (+240.8% total)n/a+22.55%2021-06-30 → 2026-06-308.8M → 24.2M (+176.4% total)n/a
FCF: n/a+43.21%2023-06-30 → 2026-06-3021M → 61.7M (+193.8% total)+19.93%2021-06-30 → 2026-06-3024.9M → 61.7M (+148.0% total)n/a
Shares: +1.48%2025-06-30 → 2026-06-3050.5M → 51.2M (+1.5% total)+2.43%2023-06-30 → 2026-06-3047.6M → 51.2M (+7.5% total)+1.89%2021-06-30 → 2026-06-3046.6M → 51.2M (+9.8% total)+7.88%2016-06-30 → 2026-06-3024M → 51.2M (+113.4% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +236.81%2025-06-30 → 2026-06-30$0.14 → $0.46 (+236.5% total)n/a+20.39%2021-06-30 → 2026-06-30$0.18 → $0.46 (+152.9% total)n/a
Sales/share: +21.18%2025-06-30 → 2026-06-30$4.94 → $5.98 (+21.2% total)+16.99%2023-06-30 → 2026-06-30$3.74 → $5.98 (+60.1% total)+15.94%2020-12-31 → 2026-06-30$2.65 → $5.98 (+125.4% total)+10.34%2016-06-30 → 2026-06-30$2.24 → $5.98 (+167.5% total)
FCF/share: n/a+39.81%2023-06-30 → 2026-06-30$0.44 → $1.20 (+173.3% total)+17.70%2021-06-30 → 2026-06-30$0.53 → $1.20 (+125.9% total)n/a
Book value/share: +18.87%2025-06-30 → 2026-06-30$6.08 → $7.23 (+18.9% total)+20.06%2023-06-30 → 2026-06-30$4.18 → $7.23 (+73.1% total)+17.40%2021-06-30 → 2026-06-30$3.24 → $7.23 (+123.0% total)+26.07%2016-06-30 → 2026-06-30$0.71 → $7.23 (+913.6% total)
Price: +15.49%2025-10-16 → 2026-10-16$34.75 → $40.13 (+15.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+6.14%2023-10-16 → 2026-10-16$33.56 → $40.13 (+19.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-4.60%2021-10-15 → 2026-10-16$50.79 → $40.13 (-21.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+32.35%2016-10-14 → 2026-10-16$2.43 → $40.13 (+1551.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +15.49%2025-10-16 → 2026-10-16$34.75 → $40.13 (+15.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+6.14%2023-10-16 → 2026-10-16$33.56 → $40.13 (+19.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.60%2021-10-15 → 2026-10-16$50.79 → $40.13 (-21.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+32.35%2016-10-14 → 2026-10-16$2.43 → $40.13 (+1551.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 88.2×2016-12 -3.962026-10 84.88-2245.4% over the window
Fwd P/E: 47.4×
P/S (ttm)Market cap ÷ TTM revenue.: 6.7×2016-12 1.362026-10 6.71+394.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 5.6×2016-12 6.352026-10 5.56-12.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 33.3×2016-12 -4.592026-10 33.34-827.2% over the window
EV/EBITDA (fy): 63.9×
EV/Sales (ttm): 6.5×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.00%2016-12 -29.5%2026-06 2.7%-109.2% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 51.2M ÷ 50.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.48%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.48%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -1.48%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-7.2M) ÷ today's market cap ($2.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -0.35%2016-09 0.0%2026-06 -0.3%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-7.2M + TTM dividends $0) ÷ today's market cap ($2.1B). Same caveat as the cash buyback yield.: -0.35%2016-09 0.0%2026-06 -0.3%

Vs own 10Y history

P/E: 6th
P/S: 31st
P/B: 14th
P/FCF: 2nd

Bar = where today’s multiple sits in VCEL’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-2.17%

+0.07%

-0.20%

-16.06%

YTD

+11.44%

+15.48%

-20.99%

Financial statements

Open full VCEL financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

VCEL — Vericel Corporation price, chart and key statistics